Parnax Lab

Parnax Lab Change in Working Capital

The Change in Working Capital of Parnax Lab (506128.BO) as of Nov 13, 2026 is 37.88 M INR. In the previous year, Change in Working Capital was -80.36 M INR — a change of -147.14% (higher).

Change in Working Capital

37.88 MINR

YoY

-147.14%

Last updated:

Change in Working Capital of Parnax Lab is 2025 37.88 M INR. Change in Working Capital of Parnax Lab was 2024 -80.36 M INR. It decreases by -147.14% higher compared to the previous year.

The Parnax Lab Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2018
2.62 M INR
Jan 1, 2019
-36.07 M INR
Jan 1, 2020
17.42 M INR
Jan 1, 2021
-38.36 M INR
Jan 1, 2022
-147.70 M INR
Jan 1, 2023
-29.53 M INR
Jan 1, 2024
-80.36 M INR
Jan 1, 2025
37.88 M INR
The Parnax Lab Change in Working Capital history
YEARChange in Working CapitalYoY
37.88 MINR-147.14%
-80.36 MINR+172.12%
-29.53 MINR-80.01%
-147.70 MINR+285.06%
-38.36 MINR-320.17%
17.42 MINR-148.30%
-36.07 MINR-1,476.71%
2.62 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Change in Working Capital of Parnax Lab is 37.88 M INR in 2025.

Change in Working Capital of Parnax Lab changed from -80.36 M INR to 37.88 M INR, representing a -147.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Parnax Lab

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Parnax Lab